Navigation Links
Adult Glioblastoma: Strategies, Challenges, and Opportunities
Date:3/24/2008

A Complimentary Continuing Education Lecture Series for Healthcare

Professionals

HADDON HEIGHTS, N.J., March 24 /PRNewswire/ -- Glioblastomas are the most common and most malignant type of glioma. Healthcare professionals face many challenges in the treatment of glioblastoma as therapy remains largely palliative, and mean length of survival in patients is less than one year.

Recent clinical trials have shown that combining surgery, radiation therapy and chemotherapy extends survival in a subset of patients, particularly when the chemotherapeutic agent temozolomide is included in the treatment approach. Other potentially promising therapies for glioblastoma under investigation include regional drug administration, targeted biological therapies, vaccines, and genomic profiling. As research continues, new agents for adult glioblastoma are expected to further extend survival.

To address the need for current education on glioblastoma, treatment strategies, challenges, and emerging therapies, Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a series of complimentary live educational lectures in institutions across the United States, as well as an online educational activity consisting of a virtual lecture presentation.

The Course Director for this continuing education opportunity is Dr. Marc C. Chamberlain, Professor of Neurology at the University of Washington and expert in the development of clinical trials for primary brain tumors. All lectures will be presented by experts in the treatment of glioblastoma. Continuing education credit will be offered for physicians, pharmacists and nurses.

Healthcare professionals can schedule a live lecture at their institution by contacting RMEI:

Online: http://www.rmei.com/GBLectures

Toll-free Phone: 1-866-770-7634, ext. 337

Email: GBLectures@rmei.com

This continuing education opportunity is jointly sponsored by Robert Michael Educational Institute LLC and Postgraduate Institute of Medicine and is supported by an educational grant from Schering-Plough.

Robert Michael Educational Institute LLC is a full-service medical education company dedicated to providing comprehensive medical education to healthcare providers, patients, and caregivers. Our mission is to design programs that improve diagnosis and treatment through a variety of educational programming such as national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Rheumatoid Arthritis Drug Works for Adults, Children
2. Research on consequences: Hyperactive girls face problems as adults
3. Eating Disorders Program at Lucile Packard Childrens Hospital Expands to Include Young Adults
4. Cystic Fibrosis Foundation announces $5 million initiative to enhance care for adults with CF
5. Cystic Fibrosis Foundation Announces $5 Million Initiative to Enhance Care for Adults with CF - as Lifespan Increases
6. Depression: the symptoms in children are not like in adults
7. Dont Prescribe Antibiotics for Adult Sinus Woes
8. Rate of escalator injuries to older adults has doubled
9. Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life
10. The Attention Deficit Disorder Association and The HealthCentral Network Form Alliance to Develop New Online Resources for Adult ADHD
11. Emergency on-field treatment for neck injuries in young sports athletes no different than adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... La. (PRWEB) , ... July 21, 2017 , ... ... allow 4th-year medical students improve their chances of acceptance to a residency in ... those who have earned degrees outside the U.S. , According to data released ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne is proud of ... her research center at Bio-Logic Aqua Research® Water Life Science®, has been released ... of sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first prospective ACL ... Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions and maintain ... decline over time. The study, presented today at the American Orthopaedic Society ...
(Date:7/21/2017)... ... July 21, 2017 , ... How ... are on the rise, say researchers presenting their work at the American ... , “The combination of evaluating the patterns of change in concussion symptom presentation, ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... manufacturing network, the Company will be ceasing operations and ... Huntsville, Alabama . The closure of the facilities ... to 18 months. The Huntsville ... products and these restructuring actions are intended to better ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/17/2017)... -- MedX Holdings, Inc., the manufacturer and global distributor of ... today announced the national roll out of its MedX ... standard for the treatment of low back injuries and ... How it works: MedX ... who prescribe the MedX Home Back Machine Program for ...
Breaking Medicine Technology: